Risk Factors and Prognostic Implications of New-Onset Paroxysmal Atrial Fibrillation in Patients Hospitalized with Intracerebral Hemorrhage

Objective We aimed to assess the prevalence and risk factors of new-onset paroxysmal atrial fibrillation (PAF) in patients hospitalized with ICH and determine whether the new-onset PAF had influenced functional outcomes. Methods We analyzed a database of all consecutive patients with ICH from October 2013 to May 2022. Univariate and multivariable regression analyses were performed to identify risk factors for new-onset PAF in patients with ICH. Multivariate models were also constructed to assess whether the new-onset PAF was an independent predictor of poor functional outcome, as measured using the modified Rankin scale. Results This study included 650 patients with ICH, among whom 24 patients had new-onset PAF. In the multivariable model, older age (OR per 10-y increase, 2.26 [95% CI, 1.52–3.35]; P<0.001), hematoma volume (OR per 10-mL increase, 1.80 [95% CI, 1.26–2.57]; P=0.001), and heart failure (OR, 21.77 [95% CI, 5.52–85.91]; P<0.001) were independent risk factors for new-onset PAF. In a sensitivity analysis restricted to 428 patients with N-terminal pro-B-type natriuretic peptide (NT-proBNP), older age, larger hematoma volume, heart failure, and increased NT-proBNP were associated with new-onset PAF. After adjusting for baseline variables, new-onset PAF was an independent predictor of poor functional outcome (OR, 10.35 [95% CI, 1.08–98.80]; P=0.042). Conclusion Older age, larger hematoma volume, and heart failure were independent risk factors for new-onset PAF after ICH. Increased NT-proBNP is correlated with higher risks for new-onset PAF when their information is available at admission. Furthermore, new-onset PAF is a significant predictor of poor functional outcome.

[1]  J. Cleland,et al.  Criteria for Iron Deficiency in Patients With Heart Failure. , 2022, Journal of the American College of Cardiology.

[2]  R. Wachter,et al.  Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial , 2021, Circulation.

[3]  P. Kirchhof,et al.  Systematic monitoring for detection of atrial fibrillation in patients with acute ischaemic stroke (MonDAFIS): a randomised, open-label, multicentre study , 2021, The Lancet Neurology.

[4]  Mark D. Huffman,et al.  Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China , 2021, Heart.

[5]  Jeroen J. Bax,et al.  2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). , 2020, European heart journal.

[6]  R. Helbok,et al.  Early Predictors for Infectious Complications in Patients With Spontaneous Intracerebral Hemorrhage and Their Impact on Outcome , 2019, Front. Neurol..

[7]  R. Delgado-Mederos,et al.  Insular damage, new‐onset atrial fibrillation and outcome after acute intracerebral hemorrhage , 2018, European journal of neurology.

[8]  S. Gosselin,et al.  Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. , 2018, CJEM.

[9]  L. Fauchier,et al.  Prediction of Incident Atrial Fibrillation According to Gender in Patients With Ischemic Stroke From a Nationwide Cohort. , 2017, American Journal of Cardiology.

[10]  C. Israel,et al.  Detection of atrial fibrillation in patients with embolic stroke of undetermined source by prolonged monitoring with implantable loop recorders , 2017, Thrombosis and Haemostasis.

[11]  Klaus Gröschel,et al.  Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label randomised controlled trial , 2017, The Lancet Neurology.

[12]  D. Hanley,et al.  Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial , 2017, The Lancet.

[13]  Seung‐Jung Park,et al.  Predictors and long-term clinical outcomes of newly developed atrial fibrillation in patients with cardiac implantable electronic devices , 2016, Medicine.

[14]  D. McManus,et al.  Atrial Fibrillation Is Associated With a Worse 90-Day Outcome Than Other Cardioembolic Stroke Subtypes , 2016, Stroke.

[15]  Vincenzo Di Lazzaro,et al.  Predictors for atrial fibrillation detection after cryptogenic stroke , 2016, Neurology.

[16]  Young-Soo Lee Atrial premature beats predict atrial fibrillation in cryptogenic stroke: results from the EMBRACE trial. , 2015 .

[17]  Yenn-Jiang Lin,et al.  Inflammation and the pathogenesis of atrial fibrillation , 2015, Nature Reviews Cardiology.

[18]  David J. Gladstone,et al.  Atrial Premature Beats Predict Atrial Fibrillation in Cryptogenic Stroke: Results From the EMBRACE Trial , 2015, Stroke.

[19]  Mårten Rosenqvist,et al.  High Prevalence of Atrial Fibrillation Among Patients With Ischemic Stroke , 2014, Stroke.

[20]  M. Kaste,et al.  In-Hospital Cardiac Complications after Intracerebral Hemorrhage , 2014, International journal of stroke : official journal of the International Stroke Society.

[21]  Frank Beckers,et al.  Cryptogenic stroke and underlying atrial fibrillation. , 2014, The New England journal of medicine.

[22]  David J Gladstone,et al.  Atrial fibrillation in patients with cryptogenic stroke. , 2014, The New England journal of medicine.

[23]  Ana Catarina Fonseca,et al.  N-Terminal Pro-Brain Natriuretic Peptide Shows Diagnostic Accuracy for Detecting Atrial Fibrillation in Cryptogenic Stroke Patients , 2014, International journal of stroke : official journal of the International Stroke Society.

[24]  W. Hacke,et al.  Prevalence of atrial fibrillation in intracerebral hemorrhage , 2014, European journal of neurology.

[25]  R. Keep,et al.  Intracerebral haemorrhage: mechanisms of injury and therapeutic targets , 2012, The Lancet Neurology.

[26]  R. Wachter,et al.  Natriuretic Peptides for the Detection of Paroxysmal Atrial Fibrillation in Patients with Cerebral Ischemia – the Find-AF Study , 2012, PloS one.

[27]  T. Steiner,et al.  Autonomic Effects of Intraventricular Extension in Intracerebral Hemorrhage , 2012, Neurocritical Care.

[28]  Jian Wang,et al.  Preclinical and clinical research on inflammation after intracerebral hemorrhage , 2010, Progress in Neurobiology.

[29]  A. Camm,et al.  Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). , 2010, European heart journal.

[30]  D. Levy,et al.  Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study , 2009, The Lancet.

[31]  A. Rupp,et al.  Impaired baroreflex sensitivity predicts outcome of acute intracerebral hemorrhage , 2008, Critical care medicine.

[32]  Hongmei Li,et al.  Neural Mechanisms of Paroxysmal Atrial Fibrillation and Paroxysmal Atrial Tachycardia in Ambulatory Canines , 2008, Circulation.

[33]  Jian Wang,et al.  Inflammation after Intracerebral Hemorrhage , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[34]  S. Avikainen,et al.  Long term survival after primary intracerebral haemorrhage: a retrospective population based study , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[35]  David Amar,et al.  Competing autonomic mechanisms precede the onset of postoperative atrial fibrillation. , 2003, Journal of the American College of Cardiology.

[36]  Keishi Kubo,et al.  Role of Autonomic Tone in the Initiation and Termination of Paroxysmal Atrial Fibrillation in Patients Without Structural Heart Disease , 2003, Journal of cardiovascular electrophysiology.

[37]  Hendrik Bonnemeier,et al.  Autonomic tone variations before the onset of paroxysmal atrial fibrillation. , 2003, Circulation.

[38]  A. Demchuk,et al.  Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy , 2000, The Lancet.

[39]  G. Kay,et al.  Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. , 1997, Journal of the American College of Cardiology.

[40]  T Brott,et al.  The ABCs of measuring intracerebral hemorrhage volumes. , 1996, Stroke.

[41]  J. Broderick,et al.  Volume of Intracerebral Hemorrhage: A Powerful and Easy‐to‐Use Predictor of 30‐Day Mortality , 1993, Stroke.

[42]  P. O’Neill,et al.  Return of atrial mechanical function following electrical conversion of atrial dysrhythmias. , 1990, American heart journal.

[43]  R Slama,et al.  [The atrial arrhythmia syndrome of vagal origin]. , 1978, Archives des maladies du coeur et des vaisseaux.

[44]  KjellAsplund,et al.  High Prevalence of Atrial Fibrillation Among Patients With Ischemic Stroke , 2014 .

[45]  R. Keep,et al.  Blood-brain barrier function in intracerebral hemorrhage. , 2008, Acta neurochirurgica. Supplement.

[46]  A. Demchuk,et al.  Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. , 2000, Lancet.